156 related articles for article (PubMed ID: 23564914)
1. Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes.
Chang J; Wu T; Greenfield JR; Samocha-Bonet D; Horowitz M; Rayner CK
Diabetes Care; 2013 Aug; 36(8):2262-5. PubMed ID: 23564914
[TBL] [Abstract][Full Text] [Related]
2. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK
Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
[TBL] [Abstract][Full Text] [Related]
4. Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans.
Wu T; Zhao BR; Bound MJ; Checklin HL; Bellon M; Little TJ; Young RL; Jones KL; Horowitz M; Rayner CK
Am J Clin Nutr; 2012 Jan; 95(1):78-83. PubMed ID: 22158727
[TBL] [Abstract][Full Text] [Related]
5. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
[TBL] [Abstract][Full Text] [Related]
6. Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin.
Wu T; Ma J; Bound MJ; Checklin H; Deacon CF; Jones KL; Horowitz M; Rayner CK
Diabetes; 2014 Aug; 63(8):2776-87. PubMed ID: 24647737
[TBL] [Abstract][Full Text] [Related]
7. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
8. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR
J Nutr; 2011 Jul; 141(7):1233-8. PubMed ID: 21593352
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
Perano SJ; Couper JJ; Horowitz M; Martin AJ; Kritas S; Sullivan T; Rayner CK
J Clin Endocrinol Metab; 2014 Jul; 99(7):2486-93. PubMed ID: 24670086
[TBL] [Abstract][Full Text] [Related]
11. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes.
Zhang X; Young RL; Bound M; Hu S; Jones KL; Horowitz M; Rayner CK; Wu T
Diabetes Care; 2019 Apr; 42(4):520-528. PubMed ID: 30765429
[TBL] [Abstract][Full Text] [Related]
13. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
[TBL] [Abstract][Full Text] [Related]
14. Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
Chowdhury S; Reeds DN; Crimmins DL; Patterson BW; Laciny E; Wang S; Tran HD; Griest TA; Rometo DA; Dunai J; Wallendorf MJ; Ladenson JH; Polonsky KS; Wice BM
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G301-9. PubMed ID: 24356886
[TBL] [Abstract][Full Text] [Related]
15. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men.
Steinert RE; Luscombe-Marsh ND; Little TJ; Standfield S; Otto B; Horowitz M; Feinle-Bisset C
J Clin Endocrinol Metab; 2014 Sep; 99(9):3275-84. PubMed ID: 24926954
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).
Ranganath L; Schaper F; Gama R; Morgan L; Wright J; Teale D; Marks V
Diabetes Metab Res Rev; 1999; 15(6):390-4. PubMed ID: 10634963
[TBL] [Abstract][Full Text] [Related]
19. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
[TBL] [Abstract][Full Text] [Related]
20. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
